Investors looking for diversified exposure to European equities often consider the iShares Core MSCI Europe ETF (IEUR) and the Vanguard FTSE Europe ETF (VGK). These are established, low-cost options that provide market-cap-weighted access to developed European stocks across large-, mid-, and small-cap segments. Both draw from many of the same leading companies, including Dutch semiconductor equipment maker ASML and Swiss pharmaceutical names. With attention on European markets amid evolving interest-rate paths, a steady financials sector, and broader geopolitical factors, it helps to understand how these two funds differ structurally.
IEUR tracks the MSCI Europe Investable Market Index, a free-float-adjusted, market-capitalization-weighted benchmark that spans large-, mid-, and small-cap companies in 15 developed European markets. The fund typically holds around 1,000 securities, with the United Kingdom accounting for roughly 20% of assets, followed by Germany, France, and Switzerland. Top holdings feature ASML, Roche, HSBC, Shell, Novartis, Nestlé, AstraZeneca (AZN), and SAP. Sector weights are led by financials at around 24%, industrials at around 19%, healthcare at around 12%, and technology at around 9%. The fund uses representative sampling, carries a net expense ratio of 0.09%, and is managed by BlackRock. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
VGK tracks the FTSE Developed Europe All Cap Index and has been available since 2005. It is the larger and more liquid option, with roughly $30 billion in assets and around 1,240 holdings. Country allocations are similar, with the United Kingdom at roughly 22%, followed by Switzerland, France, and Germany. Top holdings largely overlap with IEUR and include ASML, HSBC, Roche, Novartis, Nestlé, Shell (SHEL), AstraZeneca, Siemens, and SAP. Sector weights are led by financials at around 25%, industrials at around 20%, healthcare at around 12%, and technology at around 9%. The expense ratio stands at just 0.06%, and the fund uses full replication. From what I see, the combination of scale and lower fees gives it a noticeable structural advantage.
European equities have attracted fresh interest as investors assess monetary policy differences between the European Central Bank and the U.S. Federal Reserve. Financials, the largest sector in both funds, have benefited from a higher-for-longer rate environment that supports bank margins. Industrials remain tied to manufacturing and trade trends, while the technology exposure anchored by ASML and SAP links both ETFs to the broader capex cycle. Risks such as energy volatility, export dependence, regulatory changes, and regional geopolitics affect the two funds in nearly identical ways given their overlapping portfolios.
Because IEUR and VGK hold many of the same companies in similar proportions, their returns have moved closely together. Small differences in index construction, country weights, and small-cap exposure can lead to modest variations in volatility during style rotations, but the funds generally rise and fall together with financials, healthcare, and industrials. VGK’s slightly higher financials weighting and broader small- and mid-cap holdings can produce slight differences in return patterns. Over time, its lower expense ratio provides a persistent performance edge, while its larger asset base supports tighter spreads and better liquidity.
Based on the structural factors outlined above, Tickeron’s AI would likely favor VGK over IEUR. The edge comes from cost efficiency, scale, and diversification rather than short-term price moves: VGK’s 0.06% expense ratio versus 0.09%, its larger and more liquid asset base, and its broader roster of roughly 1,240 holdings that offers deeper small- and mid-cap exposure. With nearly identical sector and country allocations, these elements make VGK the more efficient core holding for developed European equity exposure, though IEUR remains a solid low-cost alternative.
I often turn to Tickeron’s AI Screener when comparing ETFs like these to quickly filter holdings, review technical patterns, and assess how one fund stacks up against peers. The tool lets me apply customizable criteria around fundamentals, volatility, and performance so I can make more informed allocation choices without spending hours on manual work.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
VGK saw its Momentum Indicator move above the 0 level on October 15, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 75 similar instances where the indicator turned positive. In 66 of the 75 cases, the stock moved higher in the following days. The odds of a move higher are at 88%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where VGK's RSI Oscillator exited the oversold zone, 24 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.
The Moving Average Convergence Divergence (MACD) for VGK just turned positive on October 14, 2026. Looking at past instances where VGK's MACD turned positive, the stock continued to rise in 43 of 50 cases over the following month. The odds of a continued upward trend are 86%.
Following a +1.26% 3-day Advance, the price is estimated to grow further. Considering data from situations where VGK advanced for three days, in 259 of 318 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VGK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
VGK broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for VGK entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category EuropeStock